---
title: "Elevance Health Inc. Stock Outperforms Competitors Despite Losses On The Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302925678.md"
description: "Elevance Health Inc. (ELV) stock fell 1.20% to $439.95, outperforming competitors UnitedHealth Group and Cigna during a rough trading session where the S&P 500 and Dow Jones also declined. ELV closed 2.38% below its 52-week high. Trading volume was slightly below the 50-day average."
datetime: "2026-10-23T20:40:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302925678.md)
  - [en](https://longbridge.com/en/news/302925678.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302925678.md)
generator: "portal-rs"
---

# Elevance Health Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Elevance Health Inc. (ELV) slid 1.20% to $439.95 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.52% to 7,623.68 and Dow Jones Industrial Average falling 1.23% to 52,215.16.

Elevance Health Inc. closed 2.38% below its 52-week high of $450.69, which the company reached on October 21st.

The stock demonstrated a mixed performance when compared to some of its competitors Friday, as UnitedHealth Group Inc. (UNH) fell 1.62% to $418.09, Cigna Group (CI) fell 2.83% to $306.95, and Humana Inc. (HUM) rose 0.26% to $422.07.

Trading volume (1.1 M) remained 28,751 below its 50-day average volume of 1.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled October 23, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

10-23-26 1640ET

### Related Stocks

- [ELV.US](https://longbridge.com/en/quote/ELV.US.md)

## Related News & Research

- [Is Elevance Health (ELV) Still Undervalued Following Strong Earnings And Higher 2026 Guidance?](https://longbridge.com/en/news/302983253.md)
- [Elevance Health, Inc. $ELV Shares Acquired by Robeco Institutional Asset Management B.V.](https://longbridge.com/en/news/302684364.md)
- [Elevance Health Reports Third Quarter 2026 Results; Raises Full-Year Guidance | ELV Stock News](https://longbridge.com/en/news/302545860.md)
- [Elevance Health, Inc. $ELV Stock Position Cut by Vontobel Holding Ltd.](https://longbridge.com/en/news/302257360.md)
- [ELV: Q3 outperformance lifts 2026 guidance; long-term adjusted EPS growth target remains 12%](https://longbridge.com/en/news/302542475.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**